A first-year dornase alfa treatment impact on clinical parameters of patients with cystic fibrosis: the Brazilian cystic fibrosis multicenter study

A first-year dornase alfa treatment impact on clinical parameters of patients with cystic fibrosis: the Brazilian cystic fibrosis multicenter study

OBJECTIVE: To describe the clinical impact of the first year treatment with dornase alfa, according to age groups, in a cohort of Brazilian Cystic Fibrosis (CF) patients. METHODS: The data on 152 eligible patients, from 16 CF reference centers, that answered the medical questionnaires and perfo...

Full description

Bibliographic Details
Main Authors: Tatiana Rozov, Fernando Antônio A. e Silva, Maria Angélica Santana, Fabíola Villac Adde, Rita Heloisa Mendes
Format: Article
Language:English
Published: Sociedade de Pediatria de São Paulo 2013-12-01
Series:Revista Paulista de Pediatria
Subjects:
fibrosis quística
dornasa alfa
tratamiento
evolución clínica
microbiología pulmonar
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-05822013000400420&lng=en&tlng=en

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-05822013000400420&lng=en&tlng=en

Similar Items